FosteraTM PRRS vaccine is now registered for use in Canada by Pfizer Animal Health as an aid in preventing disease associated with Porcine Reproductive and Respiratory Syndrome Virus (PRRSV), Respiratory Form, a disease that costs Canada’s pork industry an estimated $130 million annually.
Fostera PRRS is a modified live vaccine for the vaccination of healthy, susceptible swine three weeks of age, or older, in PRRSV-positive herds or seronegative pigs deemed at risk for exposure to PRRSV, as an aid in preventing respiratory disease associated with PRRSV.
“PRRSV is endemic in almost all pork-producing areas of the world,” says Walter Heuser, DVM, Swine Business Unit Director for Pfizer Animal Health. “This new modified live vaccine option will help protect growing pigs facing a PRRSV challenge, and assist the Canadian swine industry in the management of this costly disease.”
Registered for use in young pigs, Fostera PRRS helps growing pigs defend against a PRRSV challenge, allowing them to increase their post challenge weight gain compared to non-vaccinates groups. Fostera PRRS is available exclusively through Canadian veterinarians.
May 1, 2012 - Pfizer Animal Health